statements

Indrayani Biotech Ltd.

BSE: 526445

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Other Agricultural Products

7.97+0.3 (+4.32%)

26 Aug, 3:29 PM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Indrayani Biotech Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	21.09	61.57	162.93	166.23	130.23	137.83
Cost of Operating Revenue	16.56	42.04	105.56	107.64	91.62	98.37
Gross Profit	4.53	19.53	57.37	58.59	38.60	39.46
Gross Margin	21.5	31.7	35.2	35.2	29.6	28.6
Total Operating Expenses	26.49	55.45	149.05	146.37	127.22	132.50
Operating Profit	-5.40	6.12	13.88	19.86	3.01	5.33
Operating Margin	-25.6	9.9	8.5	11.9	2.3	3.9
Financing Income/(Expense) - Net	-1.81	-1.78	-5.56	-9.90	-11.24	-9.60
Profit before Taxes	-11.22	4.46	12.31	10.97	-5.74	0.30
Income Taxes	-	-	0.38	0.55	0.36	-1.86
Profit after Tax	-11.22	4.46	11.93	10.42	-6.11	2.16
PAT Margin	-53.2	7.3	7.3	6.3	-4.7	1.6
EPS - Basic - ex Extraordinary Items	-3.28	1.30	3.49	2.68	-1.34	0.48
EPS - Diluted - ex Extraordinary Items	-3.28	1.30	2.74	2.68	-1.34	0.48
EBIT	-5.40	6.12	13.88	19.86	3.01	5.33
EBITDA	-4.94	6.78	17.22	23.66	7.75	9.63
EBITDA Margin	-23.4	11.0	10.6	14.2	6.0	7.0

Balance Sheet

Abridged

Understanding Balance Sheet

Indrayani Biotech Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	PRESS
Total Current Assets	9.62	18.91	77.52	144.98	177.94	158.72
Property Plant & Equipment - Net	25.25	25.94	47.86	59.37	60.00	63.61
Total Non-Current Assets	30.43	32.49	78.44	89.03	89.95	94.71
Total Assets	40.05	51.40	155.96	234.00	267.89	253.43
Total Current Liabilities	11.81	19.48	71.91	87.07	102.48	92.98
Long Term Debt	8.15	7.34	35.69	70.66	65.42	57.89
Total Non-Current Liabilities	8.17	7.35	35.70	70.66	65.49	58.36
Total Liabilities	19.97	26.83	107.61	157.74	167.97	151.34
Total Shareholders' Equity	19.72	24.16	55.09	67.21	72.51	72.89
Minority Interest	0.36	0.41	-6.73	9.05	27.41	29.20
Total Equity	20.08	24.57	48.35	76.27	99.92	102.08
Total Liabilities & Equity	40.05	51.40	155.96	234.00	267.89	253.43

Cash Flow

Abridged

Understanding Cash Flow Statement

Indrayani Biotech Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-8.36	4.57	8.64	30.01	23.52	11.52
Working Capital - Increase/(Decrease)	6.46	-5.64	-27.39	-62.11	-48.43	14.27
Net CF from Operating Activities	-1.90	-1.07	-18.75	-32.09	-24.91	25.79
Capital Expenditures - Net	0.38	0.06	23.89	16.42	-6.09	14.17
Net CF from Investing Activities	-0.56	0.59	-47.39	-16.34	24.11	-15.22
Stock - Issuance/(Retirement) - Net	-	-	23.28	4.63	-	0.00
Debt - LT & ST - Issuance/(Retirement) - Total	1.69	1.30	44.39	44.07	24.16	-8.39
Net Cash Flow from Financing Activities	1.69	1.30	67.68	45.98	0.51	-6.60
Free Cash Flow to Equity	-0.60	0.17	1.75	-4.45	5.34	3.23
Free Operating CF net dividend	-2.29	-1.13	-42.64	-48.58	-26.29	11.62
Free Operating CF	-2.29	-1.13	-42.64	-48.58	-26.29	11.62

Business Segment Analysis

FY End:

Mar 25

Indrayani Biotech Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

milk & associated products (51.5%)₹ 71.34 CrFood Division (29.8%)₹ 41.18 CrUnallocated (11.2%)₹ 15.49 CrHealth Care (7.4%)₹ 10.27 CrEngineering Division (0.1%)₹ 0.11 Cr

Assets

Unallocated (40.0%)₹ 107.27 Crmilk & associated products (23.0%)₹ 61.68 CrFood Division (19.0%)₹ 50.95 CrHealth Care (10.0%)₹ 26.82 CrEngineering Division (8.0%)₹ 21.45 Cr

Regional Segment Analysis

Indrayani Biotech Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Indrayani Biotech Ltd.

Historical Segment Analysis

Track how Indrayani Biotech Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Sales

Assets

Business

Regional

Business

We don't have enough data to show the Capex for Indrayani Biotech Ltd..

Frequently Asked Questions

What is the revenue of Indrayani Biotech Ltd.?

The latest trailing twelve month revenue of Indrayani Biotech Ltd. is ₹ 137.83 Cr, reflecting a 1-year growth of 5.84% and a 3-year CAGR of -5.42%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Indrayani Biotech Ltd.?

The latest trailing twelve month net profit (PAT) of Indrayani Biotech Ltd. is ₹ 2.16 Cr, with a 3-year earnings CAGR of -44.07%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Indrayani Biotech Ltd.?

The trailing twelve month EBITDA of Indrayani Biotech Ltd. is approximately ₹ 5.33 Cr (based on an operating margin of 3.87%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Indrayani Biotech Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Indrayani Biotech Ltd. is 0.48. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Indrayani Biotech Ltd.?

The debt-to-equity ratio of Indrayani Biotech Ltd. stands at 1.76. The interest coverage ratio is 0.56x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Indrayani Biotech Ltd.?

The estimated book value per share of Indrayani Biotech Ltd. is 9.74 (derived from a P/B ratio of 0.82 and market price of ₹ 7.97), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Indrayani Biotech Ltd.?

The trailing twelve month operating cash flow of Indrayani Biotech Ltd. is ₹ 25.79 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Indrayani Biotech Ltd. report consolidated or standalone financials?

Indrayani Biotech Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.